Zobrazeno 1 - 10
of 11
pro vyhledávání: '"S. J. Shankar"'
Autor:
Sunil Kumar Nechipadappu, Karthika Paul, A. Sanjana, Murthy Chavali, H K Shanthala, S. J. Shankar, B H Jaswanth Gowda, Mohammed Gulzar Ahmed
Publikováno v:
Materials Today: Proceedings. 51:394-402
Efavirenz (EFV) is a Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI) class of antiretroviral drug that is included in antiretroviral therapy to treat Human Immunodeficiency Virus (HIV) patients to increase the life-span by avoiding them to de
Publikováno v:
Materials Today: Proceedings. 51:651-656
The present study was performed to find out the structural similarity of hydroalcoholic extract of abutilon indicum and standard non-steroidal anti-inflammatory drugs (NSAIDs) using various analytical and chromatography techniques. The characterizati
Autor:
S. J. Shankar, Afrasim Moin, Umme Hani, Ali Alqahtani, Yasmin Begum M, Mohammed Jafar, Gangadharappa. H.V, Riyaz Ali M. Osmani, Kumarappan Chidambaram, Mohamed Rahamathulla
Publikováno v:
Journal of Pharmaceutical Innovation. 17:1451-1462
The main objective of the research was to formulate an effervescent floating matrix tablet (EFMT) of a potential anticancer drug neratinib employed in breast cancer therapy. The drug shows poor aqueous solubility at higher pH leading to reduce therap
Autor:
A. Sanjana, Muniganti Radhakrishna, H K Shanthala, H V Jayaprakash, B H Jaswanth Gowda, Mohammed Ahmed, Karthika Paul, S. J. Shankar
Publikováno v:
International Journal of Applied Pharmaceutics. :199-205
Objective: This study aims to synthesize acetylsalicylic acid (ASA) cocrystals using valine as a coformer via a co-crystallization technique to increase the solubility and dissolution rate of ASA. Methods: The ASA-valine cocrystal (1:1 molar ratio) w
Publikováno v:
Materials Today: Proceedings. 47:4155-4161
Darunavir (DRV) is a peptidic protease inhibitor class of antiretroviral drug which is regularly included in the antiretroviral therapy with several other drugs to treat Human immunodeficiency virus (HIV) patients to avoid those developing Acquired I
Publikováno v:
International Journal of Applied Pharmaceutics. :118-130
Objective: To develop two different oral formulations such as 5-fluorouracil (5-FU) tablets and oxaliplatin (OX) microspheres which were further filled into capsules and coated with pH-sensitive polymer (eudragit S-100) for the chronotherapeutic trea
Publikováno v:
International Journal of Applied Pharmaceutics. :10-16
Nearly 40% of drugs coming to the market nowadays are having poor solvency related issues and 70% molecules in discovery pipeline are in effect fundamentally insoluble in water. Nanocrystals is an unmistakable instrument to tackle the issue identifie
Autor:
Mohamed Rahamathulla, Umme Hani, Mohammed Jafar, S. J. Shankar, M. Yasmin Begum, Ali Alqahtani, Riyaz Ali M. Osmani, Afrasim Moin, H.V. Gangadharappa, Kumarappan Chidambaram
Publikováno v:
Journal of Pharmaceutical Innovation. 17:1463-1463
This study was intended to formulate, characterize, evaluate in-vitro formulation release and dissolution studies of hydroxyapatite included microspheres of an antimicrobial drug for the disease osteomyelitis. Levofloxacin stacked hydroxyapatite micr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1c94c429d3de6791f004a943c6a8481
Publikováno v:
Indian heart journal. 35(1)